Shinpoong Pharmaceutical Co.,Ltd (KRX:019170)
12,610
-10 (-0.08%)
Last updated: Sep 9, 2025, 11:12 AM KST
KRX:019170 Revenue
Shinpoong Pharmaceutical Co.,Ltd had revenue of 58.62B KRW in the quarter ending June 30, 2025, with 4.63% growth. This brings the company's revenue in the last twelve months to 225.09B, up 7.81% year-over-year. In the year 2024, Shinpoong Pharmaceutical Co.,Ltd had annual revenue of 221.09B with 10.42% growth.
Revenue (ttm)
225.09B
Revenue Growth
+7.81%
P/S Ratio
2.97
Revenue / Employee
278.23M
Employees
809
Market Cap
668.00B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 221.09B | 20.87B | 10.42% |
Dec 31, 2023 | 200.23B | -9.06B | -4.33% |
Dec 31, 2022 | 209.29B | 20.05B | 10.60% |
Dec 31, 2021 | 189.24B | -8.51B | -4.31% |
Dec 31, 2020 | 197.75B | 8.03B | 4.23% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 5,031.69B |
Celltrion | 3,748.95B |
ALTEOGEN | 158.06B |
Yuhan | 2,165.44B |
SK Biopharmaceuticals | 620.28B |
Peptron | 5.18B |
PharmaResearch | 449.81B |
ABL Bio | 94.93B |